Research on CBD for Brain Cancer (2017) Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture. (2016) In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. (2013) Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. (2011) Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas–possible role of Cannabis inhalation. (2010) Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. (2010) Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress. (2008) Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. (2008) Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. (2008) Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? (2007) Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. (2007) Cannabinoids and gliomas. (2007) Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue. (2007) Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review). (2004) Hypothesis: cannabinoid therapy for the treatment of gliomas?